Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ziruoyu Wang
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Second Affiliated Hospital of Chongqing Medical University,
Chongqing Medical University
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Second Affiliated Hospital of Chongqing Medical University,
Chongqing Medical University
ORCID:
0000-0002-9418-5725
Observed ORCID:
0000-0002-9418-5725
OpenAlex ID:
A5089341044
Targets of tumor microenvironment for potential drug development
2024
·
Ling Zhang
, Ziruoyu Wang
, et al.
·
MedComm – Oncology
·
76
PDF
Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells
2023
·
Ziruoyu Wang
, Yanan Li
, et al.
·
Signal Transduction and Targeted Therapy
·
44
PDF
Natural product P57 induces hypothermia through targeting pyridoxal kinase
2023
·
Ruina Wang
, Lei Xiao
, et al.
·
Nature Communications
·
17
PDF
P4HA2 hydroxylates SUFU to regulate the paracrine Hedgehog signaling and promote B-cell lymphoma progression
2024
·
Quanfu Li
, Yiyang Liu
, et al.
·
Leukemia
·
12
A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells
2022
·
Jiaqi Wang
, Jiying Zhu
, et al.
·
Genes & Diseases
·
10
PDF
Microtubule dynamics is a therapeutic vulnerability in VHL-deficient renal cell carcinoma
2025
·
Yue Pu
, Ziruoyu Wang
, et al.
·
International Journal of Biological Sciences
·
4
DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells
2026
·
Yue Pu
, Ziruoyu Wang
, et al.
·
Experimental & Molecular Medicine
·
1
PDF
Single-cell-based identification of drug synergy with immunotherapy via tumor microenvironment remodeling
2026
·
Ziruoyu Wang
, Junchi Hu
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
8
Citation count:
164
H-index:
5
I10-index:
5
Year
Topic
Type